BioVie Inc.
BIVI
$1.97
-$0.10-4.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.13M | 2.15M | 1.94M | 2.29M | 2.38M |
| Depreciation & Amortization | 6.30K | 57.30K | 57.30K | 57.30K | 57.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.72M | 5.39M | 6.26M | 5.28M | 3.66M |
| Operating Income | -5.72M | -5.39M | -6.26M | -5.28M | -3.66M |
| Income Before Tax | -5.65M | -5.27M | -6.07M | -5.09M | -3.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.65M | -5.27M | -6.07M | -5.09M | -3.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.65M | -5.27M | -6.07M | -5.09M | -3.49M |
| EBIT | -5.72M | -5.39M | -6.26M | -5.28M | -3.66M |
| EBITDA | -5.71M | -5.33M | -6.21M | -5.23M | -3.61M |
| EPS Basic | -0.71 | -0.70 | -0.77 | -0.98 | -1.88 |
| Normalized Basic EPS | -0.45 | -0.44 | -0.48 | -0.61 | -1.17 |
| EPS Diluted | -0.71 | -0.70 | -0.77 | -0.98 | -1.88 |
| Normalized Diluted EPS | -0.45 | -0.44 | -0.48 | -0.61 | -1.17 |
| Average Basic Shares Outstanding | 7.92M | 7.54M | 7.92M | 5.21M | 1.86M |
| Average Diluted Shares Outstanding | 7.92M | 7.54M | 7.92M | 5.21M | 1.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |